Access

Access

Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in genomics, we have the obligation to drive down the cost of sequencing, expand access to diagnostics technology, and increase the diversity of genomics data to realize health equity for billions of people around the world.

Content from this campaign

Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
SAN DIEGO, May 18, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, and Allegheny Health Network (AHN), an integrated health system serving the Western Pennsylvania area, today announced a collaboration to evaluate the impact of in-house comprehensive genomic...
May 19, 2022 10:00 AM ET
Illumina Partners With Allelica, Inc.
By Susan TousiChief Commercial Officer at Illumina Customers and our partners represent the heartbeat of Illumina. They help us advance our mission to improve human health through unlocking the power of the genome. And as we enter further...
May 11, 2022 10:00 AM ET
Illumina and Deerfield Management Partner to Accelerate Drug Development
SAN DIEGO, May 5, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, today announced a five-year partnership to apply a genetic-led approach to the discovery and development of novel therapies for diseases with unmet medical needs. The partnership aims to leverage...
May 9, 2022 10:00 AM ET
Illumina Announces Long-Term Strategic Partnership with Janssen
Collaboration aims to enable personalized, highly effective therapies for each tumor type and enable early detection through screening and monitoring tests.  Illumina data analytics platforms and collaborative lab services will enable more effective and efficient drug discovery by harnessing the power of genomics.
May 2, 2022 10:00 AM ET
How Collaboration Is Driving the Next Wave of Genomics
BY FASTCO WORKS​ RESHAPING MEDICINE Illumina’s advances in genetic sequencing are reshaping medicine. Genetic sequencing has now allowed cancer patients to find treatment options specific to their tumors, doctors to anticipate adverse drug reactions and personalize medicine, public health...
Apr 29, 2022 9:00 AM ET

Pages

  • 2
  • 3
  • 4
  • 5